Clinical Trials on Hair Diseases in Japan

Total 6947 results

Allergan

Completed

Safety and Efficacy Study of Bimatoprost in Japanese Patients With Eyelash Hypotrichosis

Eyelash Hypotrichosis

Japan
Allergan

Completed

Safety and Efficacy Study of Bimatoprost in Japanese Patients With Chemotherapy-Induced Eyelash Hypotrichosis

Eyelash Hypotrichosis

Japan
Allergan

Completed

Safety and Patient Satisfaction With GLASH VISTA™ (Bimatoprost 0.03%) in the Treatment of Eyelash Hypotrichosis in Japan

Eyelash Hypotrichosis

Japan
Hamamatsu University

Unknown

The Effect of 0.5% Roxithromycin Lotion for Androgenetic Alopecia

Alopecia

Japan
Pfizer

Recruiting

Litfulo Capsules Special Investigation

Alopecia Areata

Japan
GlaxoSmithKline

Completed

A Long-term Study to Determine Safety and Efficacy of Dutasteride in Male Subjects With Androgenetic Alopecia

Alopecia

Japan
Janssen Research & Development, LLC

Withdrawn

A Study of JNJ-64304500 in Participants With Alopecia Areata

Alopecia Areata

United States, Japan, France, Australia
Bristol-Myers Squibb

Terminated

A Study to Evaluate Efficacy and Safety of Deucravacitinib in Participants With Alopecia Areata

Alopecia Areata

Canada, France, Japan, Australia, United States, Poland
Eli Lilly and Company
Incyte Corporation

Active, not recruiting

A Study of Baricitinib (LY3009104) in Participants With Severe or Very Severe Alopecia Areata (BRAVE-AA1)

Alopecia Areata

United States, Japan, Puerto Rico, Mexico, Korea, Republic of
GlaxoSmithKline

Completed

Dutasteride Versus Placebo and Finasteride in Men With Androgenetic Alopecia

Androgenetic Alopecia

Japan, Argentina, Peru, Philippines, Taiwan, Mexico, Chile, Russian Federation, Thailand
AbbVie

Recruiting

A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata (Up-AA)

Alopecia Areata

United States, Australia, Japan, Puerto Rico, New Zealand, China, Canada, Brazil, United Kingdom, Korea, Republic of, Chile
Eli Lilly and Company
Incyte Corporation

Active, not recruiting

A Study of Baricitinib (LY3009104) in Adults With Severe or Very Severe Alopecia Areata (BRAVE-AA2)

Alopecia Areata

Israel, China, United States, Puerto Rico, Korea, Republic of, Taiwan, Australia, Japan, Brazil, Argentina
Pfizer

Completed

PF-06651600 for the Treatment of Alopecia Areata (ALLEGRO-2b/3)

Alopecia Areata

China, United States, Spain, Korea, Republic of, Taiwan, Canada, Australia, Germany, Czechia, Poland, Hungary, Japan, United Kingdom, Argentina, Chile, Colombia, Mexico, Russian Federation
Eli Lilly and Company

Recruiting

A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata (BRAVE-AA-PEDS)

Skin Diseases | Pathological Conditions, Anatomical | Alopecia | Hypotrichosis | Hair Diseases | Areata Alopecia

United States, Japan, Taiwan, Korea, Republic of, Spain, Germany, France, Mexico, Canada, Poland, Australia, Hungary, Argentina
Pfizer

Active, not recruiting

Long-Term PF-06651600 for the Treatment of Alopecia Areata (ALLEGRO-LT)

Alopecia Areata

United States, Spain, China, Korea, Republic of, Taiwan, Australia, Canada, Germany, Czechia, Poland, Japan, United Kingdom, Mexico, Argentina, Chile, Colombia, Russian Federation
Bayer

Completed

A Study to Learn About Venous Thromboembolism (VTE) Treatment With Rivaroxaban in Japanese Patients Using a Claims Database

Treatment of Venous Thromboembolism

Japan
AstraZeneca
Mitsubishi Tanabe Pharma Corporation

Completed

Efficacy and Safety of Roflumilast in Japanese Patients Older Than 40 Years With Chronic Obstructive Pulmonary Disease (APTA-2217-06)

Chronic Obstructive Pulmonary Disease (COPD)

Japan
Takeda

Recruiting

Specified Drug-Use Survey on Vedolizumab for IV Infusion 300 mg [Crohn's Disease]

Crohn's Disease

Japan
Kumamoto University

Active, not recruiting

Prospective Study of End Stage Renal Disease Patients With Coronary Artery Disease Treated by Oral Nicorandil

Coronary Artery Disease | End Stage Renal Disease

Japan
Takeshi Morimoto

Recruiting

Efficacy and Safety of Aspirin in Patients With Chronic Coronary Syndromes Without Revascularization (ASA-IN)

Coronary Artery Disease | Ischemic Heart Disease | Stable Angina Pectoris

Japan
Medtronic Vascular

Completed

RESOLUTE Japan SVS: The Clinical Evaluation of the MDT-4107 DES in the Treatment of De Novo Lesions in Small Diameter Native Coronary Arteries (RJ-SVS)

Myocardial Ischemia | Cardiovascular Diseases | Coronary Artery Disease | Arterial Occlusive Diseases

Japan
Cook Group Incorporated

Completed

Zilver Flex Post-Market Study in Japan

Peripheral Arterial Disease (PAD)

Japan
Sanofi

Completed

Safety Evaluation of Clopidogrel Sulfate in Patients With Peripheral Arterial Disease

Peripheral Arterial Disease (PAD)

Japan
Ito Hospital

Completed

Antimicrobial Prophylaxis in Thyroid and Parathyroid Surgery (Ito-RCT1)

Thyroid Disease | Parathyroid Disease

Japan
Kyoto University, Graduate School of Medicine

Active, not recruiting

ShorT and OPtimal Duration of Dual AntiPlatelet Therapy-2 Study (STOPDAPT-2)

Coronary Artery Disease

Japan
Kobe University

Unknown

Multicenter Comparison of Early and Late Vascular Responses to Everolimus-eluting Cobalt-CHromium Stent

Coronary Artery Disease

Japan
Fujita Health University

Unknown

Comparison Between OFDI and IVUS in PCI Guidance for Biolimus A9 Eluting Stent Implantation (MISTIC-1)

Coronary Artery Disease

Japan
Teikyo University

Unknown

3-Month Discontinuation of Dual Antiplatelet Therapy After Ultimaster Sirolimus-Eluting Stent Implantation (MODEL U-SES)

Coronary Artery Disease

Japan
Kumamoto University

Completed

Evaluation of Cardiac CT Appropriateness at Second-generation 320-row CT

Coronary Artery Disease | Cardiac CT

Japan
Osaka City University

Unknown

Efficacy and Safety of Tamibarotene (OAM80) for Alzheimer's Disease

Alzheimer's Disease

Japan
Nagoya University

Unknown

TACT-NAGOYA: Therapeutic Angiogenesis Using Cell Transplantation

Buerger Disease | Arteriosclerosis Obliterans

Japan
Kyowa Kirin Co., Ltd.

Completed

Long-Term Safety Study of KW-6002 (Istradefylline) in Parkinson's Disease Patients (6002-010)

Parkinson's Disease

Japan
Kyowa Kirin Co., Ltd.

Completed

A Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease

Parkinson's Disease

Japan
Chieko Hamada

Terminated

Differential Intervention Trial by Standard Therapy Versus Pitavastatin in Patients With Chronic Hemodialysis (DIALYSIS)

Cardiovascular Disease

Japan
Novartis

Completed

SPP100 (Aliskiren) Regimen in Patients With Severe Hypertension

Hypertension

Japan
Juntendo University
Japan Heart Foundation

Completed

Azelnidipine Anti-Coronary Atherosclerotic Trial in Hypertensive Patients by Serial Volumetric IVUS Analysis(ALPS-J)

Hypertension | Coronary Atherosclerosis

Japan
GlaxoSmithKline

Completed

Clinical Evaluation Of GW815SF For Chronic Obstructive Pulmonary Disease (Chronic Bronchitis, Emphysema)

Pulmonary Disease, Chronic Obstructive

Japan
Sanofi
Regeneron Pharmaceuticals

Completed

Dupilumab in Japanese Patients With Chronic Rhinosinusitis With Nasal Polyp (SINUS-M52)

Chronic Rhinosinusitis With Nasal Polyps

Japan
Kumamoto University

Completed

Comparison of Pitavastatin With Atorvastatin in Increasing High Density Lipoprotein - Cholesterol (HDL-C) and Adiponectin in Patients With Dyslipidemia and Coronary Artery Disease (CAD) (COMPACT-CAD)

Coronary Artery Disease | Hypercholesterolemia

Japan
Kumamoto University

Completed

Prognostic Value of Endothelial Dysfunction and Coronary Complexity

Cardiovascular Disease

Japan
Kyoto University, Graduate School of Medicine

Active, not recruiting

ShorT and OPtimal Duration of Dual AntiPlatelet Therapy-2 Study for the Patients With ACS (STOPDAPT-2 ACS)

Coronary Artery Disease | Acute Coronary Syndrome | Percutaneous Coronary Intervention | Acute Myocardial Infarction | Platelet Aggregation Inhibitors

Japan
AstraZeneca
Mitsubishi Tanabe Pharma Corporation

Completed

Long-term Study of Safety and Efficacy of Roflumilast in Japanese Patients Older Than 40 Years With Chronic Obstructive Pulmonary Disease (APTA-2217-08)

Chronic Obstructive Pulmonary Disease (COPD)

Japan
Alcon Research

Completed

Clinical Pharmacological Study of AL-43546 Ophthalmic Product in Subjects With Shortened Tear Film Break Up Time

Dry Eye Disease

Japan
GlaxoSmithKline

Completed

ADOAIR250 Anti-inflammatory Effects in Japanese Subjects With Chronic Obstructive Pulmonary Disease

Pulmonary Disease, Chronic Obstructive

Japan
GlaxoSmithKline

Completed

Study of Danirixin in Japanese Healthy Elderly Male Subjects

Pulmonary Disease, Chronic Obstructive

Japan
GlaxoSmithKline

Completed

Special Drug Use Investigation for ADOAIR DISKUS COPD (Salmeterol and Fluticasone)

Pulmonary Disease, Chronic Obstructive

Japan
Abbott Medical Devices

Completed

XIENCE PRIME Japan Post-Marketing Surveillance (PMS)

Myocardial Ischemia | Coronary Artery Disease | Coronary Occlusion | Coronary Artery Stenosis | Angina

Japan
Translational Research Center for Medical Innovation...
Niigata University

Completed

Renal Prognosis in Chronic Kidney Disease Patients With Hyporesponsive Anemia to Erythropoiesis Stimulating Agents (BRIGHTEN)

Chronic Kidney Disease | Renal Anemia

Japan
Kyoto University, Graduate School of Medicine
Kyoto Prefectural University of Medicine

Withdrawn

Home Blood Pressure-guided Antihypertensive Intervention for Elderly (HBP-GUIDE) Study

Hypertension | Cardiovascular Disease | Vascular Disease

Japan
Kyoto Prefectural University of Medicine

Completed

Add-on Effects of Valsartan on Morbi- Mortality (KYOTO HEART Study)

Stroke | Hypertension | Ischemic Heart Disease | Congestive Heart Failure

Japan

Clinical Trials on Hair Diseases in Japan

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Suriname

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations